Tapentadol, Screen and Confirmation, Urine
Also known as: Nucynta®
Use
Detect and confirm the presence of tapentadol
Special Instructions
This assay is designed for pain management. It is not intended for workplace testing and does not comply with state regulatory workplace testing programs.
Limitations
The test was developed by LabCorp and its performance characteristics were determined by the laboratory. It has not been cleared or approved by the US Food and Drug Administration (FDA). Therefore, its use is limited to clinical settings where FDA approval is not necessary.
Methodology
Immunoassay (ELISA)
Biomarkers
LOINC Codes
- 72485-6
- 72485-6
Result Turnaround Time
3-5 days
Related Documents
For more information, please review the documents below
Specimen
Urine
Volume
20 mL
Minimum Volume
Not provided
Container
Plastic urine container
Storage Instructions
Maintain specimen at room temperature. If arrival at lab will extend beyond seven days, refrigerate.
Other tests from different labs that may be relevant